FAILURE OF ERYTHROMYCIN ESTOLATE THERAPY IN IN UTERO SYPHILIS.
D000293:Adolescent; D004358:Drug Therapy; D004917:Erythromycin; D004918:Erythromycin Estolate; D005029:Ethylenediamines; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D008431:Maternal-Fetal Exchange; D010400:Penicillin G; D010401:Penicillin G Benzathine; D011247:Pregnancy; D011248:Pregnancy Complications; D011251:Pregnancy Complications, Infectious; D013587:Syphilis; D013590:Syphilis, Congenital
D005029:Ethylenediamines; D004917:Erythromycin; C010044:benzathine; D010400:Penicillin G; D010401:Penicillin G Benzathine; D004918:Erythromycin Estolate
ADOLESCENCE; DRUG THERAPY; ERYTHROMYCIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MATERNAL-FETAL EXCHANGE; PENICILLIN G, BENZATHINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYPHILIS; SYPHILIS, CONGENITAL